CSP
2 min read
38

Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (07.11.2024)

November 8, 2024
0

Reading Time: 2 minutes Kesko Corporation has on 8 November 2024 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 7 November 2024, BlackRock, Inc.’s holding in Kesko Corporation, including holding

Continue Reading
CSP
19 min read
83

Filo Reports Q3 2024 Results

November 8, 2024
0

Reading Time: 14 minutes VANCOUVER, BC, Nov. 8, 2024 /CNW/ – Filo Corp. (TSX: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo”, or the “Company”) announces its results for the three and nine months ended September 30, 2024. Jamie Beck, President & CEO,

Continue Reading
CSP
7 min read
44

The Board of Directors of DUG Foodtech has resolved on a directed set-off issue of approximately SEK 7 million

November 8, 2024
0

Reading Time: 5 minutes 8 November, 2024, Lund, Sweden   The Board of Directors of DUG Foodtech AB (publ) (“DUG Foodtech” or the “Company”) has today, November 8, by virtue of authorization granted by the extraordinary general meeting on October 15, 2024, resolved on a

Continue Reading
CSP
1 min read
44

Nordea Bank Abp: Repurchase of own shares on 08.11.2024

November 8, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares08.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 08.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc
CSP
7 min read
43

Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc

November 8, 2024
0

Reading Time: 5 minutes Nightingale Health PlcCompany release8 November 2024 at 5:00 p.m. (EET) The Annual General Meeting of Nightingale Health Plc was held on 8 November 2024. The meeting was held as a fully virtual remote meeting in accordance with Chapter 5, Section

Continue Reading
CSP
1 min read
40

#24-385 Correction of #24-384 Information regarding issuer substitution for Credit Suisse International

November 8, 2024
0

Reading Time: < 1 minute Due to a merger between Credit Suisse and UBS, instrument with isin XS1973489682 will undergo an issuer substitution. Instrument previously issued by Credit Suisse International will change issuer to UBS AG with effective date 11th of November. For more details,

Continue Reading
CSP
3 min read
42

CasinoRank Reveals Insights on Emerging Online Casino Markets

November 8, 2024
0

Reading Time: 2 minutes November 8, 2024 – As the online casino industry expands globally, certain regions are fast becoming hubs of opportunity. CasinoRank, a trusted name in online casino insights and rankings, highlights regions like India, Brazil, Africa, Latin America, and Southeast Asia, where younger

Continue Reading
CSP
2 min read
37

Panoro Energy ASA – Announces Transactions Made Under the Company’s Share Buyback Program

November 8, 2024
0

Reading Time: 2 minutes Oslo, 08 November 2024 – Panoro Energy ASA (“Panoro” or the “Company”) (OSE: PEN) initiated a share buyback program on May 23, 2024 to repurchase up to NOK 100 million in value of the Company’s common shares in open market transactions

Continue Reading
CSP
1 min read
38

#24-386 Listing of Derivatives at NGM

November 8, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
40

#24-384 Information regarding issuer substitution for Credit Suisse International

November 8, 2024
0

Reading Time: < 1 minute Due to a merger between Credit Suisse and UBS, instrument with ISIN XS1973489682 will undergo an issuer substitution. Instrument previously issued by Credit Suisse International will change issuer to UBS AG with effective date 11th of November For more details, see attached

Continue Reading